Ginkgo Bioworks Holdings, Inc. Submits Form 144 Filing – (Subject)
Ginkgo Bioworks Holdings, Inc. recently filed a Form 144 with the Securities and Exchange Commission (SEC), indicating that certain shareholders, including company executives, directors, and large investors, are planning to sell a portion of their shares. Form 144 is required when insiders of a company plan to sell their shares and serves as a notice of their intent to sell within a specific timeframe.
Ginkgo Bioworks Holdings, Inc. is a biotechnology company that designs custom microbes for a variety of industries, including agriculture, pharmaceuticals, and food. The company utilizes its platform to engineer biology for various applications, ranging from creating fragrances to developing proteins for food products. With a focus on sustainability and innovation, Ginkgo Bioworks has established itself as a leader in the synthetic biology space.
For more information about Ginkgo Bioworks Holdings, Inc., please visit their official website here.
Read More:
Ginkgo Bioworks Holdings, Inc. Files Form 144 with SEC
